SG138623A1 - Use of ppr delta agonists for treating demyelinating diseases - Google Patents
Use of ppr delta agonists for treating demyelinating diseasesInfo
- Publication number
- SG138623A1 SG138623A1 SG200800123-2A SG2008001232A SG138623A1 SG 138623 A1 SG138623 A1 SG 138623A1 SG 2008001232 A SG2008001232 A SG 2008001232A SG 138623 A1 SG138623 A1 SG 138623A1
- Authority
- SG
- Singapore
- Prior art keywords
- ppr
- demyelinating diseases
- delta agonists
- treating demyelinating
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55853304P | 2004-04-01 | 2004-04-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG138623A1 true SG138623A1 (en) | 2008-01-28 |
Family
ID=34977094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200800123-2A SG138623A1 (en) | 2004-04-01 | 2005-03-29 | Use of ppr delta agonists for treating demyelinating diseases |
Country Status (16)
Country | Link |
---|---|
US (1) | US20070149580A1 (fr) |
EP (1) | EP1737440A2 (fr) |
JP (1) | JP2007530703A (fr) |
KR (1) | KR20060134191A (fr) |
CN (1) | CN1950077A (fr) |
AU (1) | AU2005231358A1 (fr) |
BR (1) | BRPI0509540A (fr) |
CA (1) | CA2561159A1 (fr) |
IL (1) | IL178165A0 (fr) |
MA (1) | MA28561B1 (fr) |
MX (1) | MXPA06011218A (fr) |
NO (1) | NO20064985L (fr) |
RU (1) | RU2006138495A (fr) |
SG (1) | SG138623A1 (fr) |
WO (1) | WO2005097098A2 (fr) |
ZA (1) | ZA200607850B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7968723B2 (en) | 2004-05-05 | 2011-06-28 | High Point Pharmaceuticals, Llc | Compounds, their preparation and use |
US8053598B2 (en) | 2004-05-05 | 2011-11-08 | High Point Pharmaceuticals, Llc | Compounds, their preparation and use |
EP2298742B1 (fr) | 2005-06-30 | 2014-01-08 | High Point Pharmaceuticals, LLC | acides phénoxyacétiques en tant qu'activateurs PPAR delta |
JP5186217B2 (ja) * | 2005-11-28 | 2013-04-17 | 千寿製薬株式会社 | Pparアゴニスト含有医薬 |
BRPI0620468A2 (pt) | 2005-12-22 | 2011-11-08 | Transtech Pharma Inc | ácidos fenóxi acéticos como ativadores de ppar delta |
CA2645719A1 (fr) | 2006-03-09 | 2007-09-13 | High Point Pharmaceuticals, Llc | Nouveaux composes, leur preparation et utilisation |
MX2010013264A (es) | 2008-06-09 | 2011-02-25 | Sanofi Aventis | Sulfonamidas n-heterociclicas aneladas con grupo de cabeza de oxadiazolona, procesos para su preparacion y su uso como sustancias farmaceuticas. |
WO2010000353A1 (fr) | 2008-06-09 | 2010-01-07 | Sanofi-Aventis | Sulfonamides comprenant un hétérocycle et un groupe de tête oxadiazolone, procédés pour les préparer et leur utilisation comme produits pharmaceutiques |
CA2774999A1 (fr) | 2009-09-30 | 2011-04-07 | President And Fellows Of Harvard College | Procedes de modulation de l'autophagie par la modulation de produits geniques renforcant l'autophagie |
AU2010340238B2 (en) | 2009-12-17 | 2016-07-21 | Sanofi | Animal model expressing luciferase under control of the myelin basic protein promoter (MBP-luci) and use of the model for bioluminescence in vivo imaging |
EP3502236B1 (fr) * | 2011-02-18 | 2023-08-23 | The Scripps Research Institute | Différenciation dirigée de cellules précurseurs d'oligodendrocytes vers un destin de cellules myélinisantes |
WO2015035171A1 (fr) | 2013-09-09 | 2015-03-12 | High Point Pharmaceuticals, Llc | Utilisation d'un agoniste de ppar-delta pour le traitement d'une amyotrophie |
WO2023147309A1 (fr) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Utilisation d'agonistes ppar-delta dans le traitement d'une maladie |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997028149A1 (fr) * | 1996-02-02 | 1997-08-07 | Merck & Co., Inc. | Procede pour augmenter les niveaux de cholesterol hdl |
GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
AU2001288271A1 (en) * | 2000-08-17 | 2002-02-25 | Harrihar A. Pershadsingh | Methods for treating inflammatory diseases |
GB0024362D0 (en) * | 2000-10-05 | 2000-11-22 | Glaxo Group Ltd | Medicaments |
GB0024361D0 (en) * | 2000-10-05 | 2000-11-22 | Glaxo Group Ltd | Medicaments |
WO2004082621A2 (fr) * | 2003-03-15 | 2004-09-30 | Bethesda Pharmaceuticals, Inc. | Nouveaux agonistes ppar, compositions pharmaceutiques et leurs utilisations |
EP1637161A4 (fr) * | 2003-04-22 | 2007-06-27 | Astellas Pharma Inc | REMEDE CONTRE DES MALADIES CEREBRALES NEURODEGENERATIVES UTILISANT UN AGONISTE DES PPAR [delta] |
-
2005
- 2005-03-29 SG SG200800123-2A patent/SG138623A1/en unknown
- 2005-03-29 JP JP2007506442A patent/JP2007530703A/ja not_active Abandoned
- 2005-03-29 WO PCT/US2005/010371 patent/WO2005097098A2/fr active Application Filing
- 2005-03-29 CA CA002561159A patent/CA2561159A1/fr not_active Abandoned
- 2005-03-29 AU AU2005231358A patent/AU2005231358A1/en not_active Abandoned
- 2005-03-29 MX MXPA06011218A patent/MXPA06011218A/es not_active Application Discontinuation
- 2005-03-29 RU RU2006138495/14A patent/RU2006138495A/ru not_active Application Discontinuation
- 2005-03-29 KR KR1020067022955A patent/KR20060134191A/ko not_active Application Discontinuation
- 2005-03-29 BR BRPI0509540-9A patent/BRPI0509540A/pt not_active IP Right Cessation
- 2005-03-29 EP EP05729215A patent/EP1737440A2/fr not_active Withdrawn
- 2005-03-29 CN CNA2005800148506A patent/CN1950077A/zh active Pending
-
2006
- 2006-09-18 IL IL178165A patent/IL178165A0/en unknown
- 2006-09-19 ZA ZA200607850A patent/ZA200607850B/xx unknown
- 2006-09-26 US US11/535,240 patent/US20070149580A1/en not_active Abandoned
- 2006-10-31 NO NO20064985A patent/NO20064985L/no not_active Application Discontinuation
- 2006-10-31 MA MA29427A patent/MA28561B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2005231358A1 (en) | 2005-10-20 |
NO20064985L (no) | 2006-10-31 |
ZA200607850B (en) | 2008-10-29 |
MA28561B1 (fr) | 2007-04-03 |
KR20060134191A (ko) | 2006-12-27 |
MXPA06011218A (es) | 2007-01-16 |
US20070149580A1 (en) | 2007-06-28 |
RU2006138495A (ru) | 2008-05-10 |
WO2005097098A3 (fr) | 2005-12-22 |
WO2005097098A2 (fr) | 2005-10-20 |
EP1737440A2 (fr) | 2007-01-03 |
IL178165A0 (en) | 2008-03-20 |
BRPI0509540A (pt) | 2007-09-18 |
JP2007530703A (ja) | 2007-11-01 |
CA2561159A1 (fr) | 2005-10-20 |
CN1950077A (zh) | 2007-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL178165A0 (en) | Use of ppr delta agonists for treating demyelinating diseases | |
EP2063897A4 (fr) | Inhibiteurs de kinases utiles pour le traitement de maladies prolifératives | |
EP2063896A4 (fr) | Inhibiteurs de la kinase utiles dans le traitement de maladies prolifératives | |
HK1139036A1 (en) | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases | |
PL2001892T3 (pl) | Imidazolotiazolowe związki do leczenia chorób proliferacyjnych | |
ZA200801253B (en) | Novel use of peptide compounds for treating muscle pain | |
ATE542823T1 (de) | 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen | |
IL227841A0 (en) | Dihydropyridinones for the treatment of cancer | |
HK1171736A1 (en) | Substituted acids for the treatment of respiratory diseases | |
IL176028A0 (en) | Compounds for treatment of cell proliferative diseases | |
IL173386A0 (en) | Use of adcc-optimized antibodies for treating weak patients | |
EP1737482A4 (fr) | Compositions et methodes de traitement de maladies | |
EP2063889A4 (fr) | Inhibiteurs de la spiropipéridine bêta-sécrétase pour le traitement de la maladie d'alzheimer | |
EP2019649A4 (fr) | Compositions et méthodes pour traiter ou prévenir des maladies de voies du corps | |
IL184934A0 (en) | 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases | |
IL179210A0 (en) | Heterocyclic derivatives for treatment of hyperlipidemia and related diseases | |
EP1750513A4 (fr) | Utilisation de ligands gpcr54 pour le traitement de l'infertilite | |
EP1867640A4 (fr) | Agent pour le traitement d'une tumeur solide | |
EP1709155A4 (fr) | Composes et compositions destines au traitement de maladies dysplasiques, et leurs methodes d'utilisation | |
EP1701735A4 (fr) | Procedes et compositions a utiliser pour le traitement des diabetes | |
HK1090377A1 (en) | Process for the preparation of tubulin inhibitors | |
ZA200704971B (en) | Pyrid-2-ones useful as inhibitors of Tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases | |
PT1742937E (pt) | Derivados de pirrolopirimidina úteis para o tratamento de doenças proliferativas | |
IL188894A0 (en) | Compounds for treatment of lipase-mediated diseases | |
ZA200606780B (en) | Compounds for the treatment of diseases |